228. Application of a Telemedicine Platform, Isolation Communication Management System (iSOCOMS), for the Care of Dangerous Infectious Disease: A Case Series
Session: Poster Abstract Session: Clinical Practice Costs, Informatics, and Telemedicine
Thursday, October 8, 2015
Room: Poster Hall
  • IDWEEK2015iSOCOMS.pdf (3.2 MB)
  • Background: Isolation is needed for the safe care of patients with potentially highly contagious and virulent infectious agents (e.g. Ebola, MERS-CoV).  We hypothesized that telemedicine could be a unique tool to improve team safety and enhance patient care for individuals with these conditions.  Isolation Communication Management System (iSOCOMS) was developed to: reducing staff exposure when communicating with patient;  facilitating student involvement without potential exposure;  improved monitoring of patient and staff;  patient support through family contact, chaplaincy, and family unencumbered by PPE;  and monitoring patient movement into the unit.

    Methods: iSOCOMS uses secure, standards-based Cisco Infrastructure to allow for the integration of fixed end-points, desktop video-conferencing, mobile telehealth and on-line telehealth education through Star Telehealth.

    Results:   iSOCOMS has been tested for the care of 3 PUI with over 194 hours of continuous use. 

    PUI Case


    CDC Risk Category

    Use (hr)

    Final Dx


    9 - 2014





    3 - 2015





    4 - 2015




    iSOCOMS enhanced patient-provider communication (Figs 1 & 2), improved physical exams (Fig 2), increased interaction between team members (Fig 2), and enabled real time observation of patient transport (Fig 3). This real time observation tool also extended physician involvement in care outside of the patient's room, reduced the pool of physicians needed to care for patients, and identified opportunities for improvement.

    Conclusion: iSOCOMS is an innovative use of telemedicine to create “virtual PPE” for the care of patients with the potential high-risk pathogens and has been rapidly adopted at our center as an essential tool for the delivery of safe and quality care of patients with potential EVD.  We believe iSOCOMS can be used for the care of patients with a wide array of infectious agents to enhance provider safety, improve patient care, and increase patient satisfaction.


    Kyle Enfield, MD MS1, Beth Mehring, RN2, Rick Carpenter, RN, MSN3, Karen Rheuban, MD4, David Cattell-Gordon, MSW4, David Gunnell, CTC5, Thomas Corey, CTC4, Virginia Burke, CTC4, Richard Rose II, CTC4 and Costi D. Sifri, MD, FIDSA6, (1)Department of Medicine, Division of Pulmonology, Hospital Epidemiology/Infection Prevention and Control, Medical Director - Medical Intensive Care Unit, University of Virginia Health System, Charlottesville, VA, (2)Emergency Management, University of Virginia, Charlottesville, VA, (3)University of Virginia, Charlottesville, VA, (4)UVA Center for Telehealth, University of Virginia, Charlottesville, VA, (5)`, University of Virginia, Charlottesville, VA, (6)Department of Medicine, Division of Infectious Diseases and International Health, Hospital Epidemiology/Infection Prevention and Control, University of Virginia Health System, Charlottesville, VA


    K. Enfield, None

    B. Mehring, None

    R. Carpenter, None

    K. Rheuban, None

    D. Cattell-Gordon, None

    D. Gunnell, None

    T. Corey, None

    V. Burke, None

    R. Rose II, None

    C. D. Sifri, None

    << Previous Abstract | Next Abstract

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.